HEADER TRANSFERASE 09-FEB-23 8CIJ TITLE CRYSTAL STRUCTURE OF HUMAN HPK1 (MAP4K1) COMPLEX WITH 2-[8-AMINO-7- TITLE 2 FLUORO-6-(8-METHYL-2,3-DIHYDRO-1H-PYRIDO[2,3-B][1,4]OXAZIN-7-YL)- TITLE 3 ISOQUINOLIN-3-YLAMINO]-6-ISOPROPYL-5,6-DIHYDRO-4H-1,6,8A-TRIAZA- TITLE 4 AZULEN-7-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HEMATOPOIETIC PROGENITOR KINASE,MAPK/ERK KINASE KINASE COMPND 5 KINASE 1,MEK KINASE KINASE 1,MEKKK 1; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP4K1, HPK1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PROTEIN KINASE, SIGNALING PROTEIN, TRANSFERASE, MAP4K1, HEMATOPOIETIC KEYWDS 2 PROGENITOR KINASE EXPDTA X-RAY DIFFRACTION AUTHOR D.MUSIL,M.TOURE REVDAT 1 16-AUG-23 8CIJ 0 JRNL AUTH M.TOURE,T.JOHNSON,B.LI,R.SCHMIDT,H.MA,C.NEAGU,A.U.LOPEZ, JRNL AUTH 2 Y.WANG,S.GULER,Y.XIAO,R.HENKES,K.HO,S.ZHANG,C.L.CHU, JRNL AUTH 3 U.M.GUNDRA,F.PORICHIS,L.LI,C.K.MAURER,Z.FANG,D.MUSIL, JRNL AUTH 4 M.DIPOTO,E.FRIIS,R.JONES,C.JONES,J.CUMMINGS,E.CHEKLER, JRNL AUTH 5 E.M.TANZER,B.HUCK,B.SHERER JRNL TITL DISCOVERY OF QUINAZOLINE HPK1 INHIBITORS WITH HIGH CELLULAR JRNL TITL 2 POTENCY. JRNL REF BIOORG.MED.CHEM. V. 92 17423 2023 JRNL REFN ESSN 1464-3391 JRNL PMID 37531921 JRNL DOI 10.1016/J.BMC.2023.117423 REMARK 2 REMARK 2 RESOLUTION. 2.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.82 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 65.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 82.0 REMARK 3 NUMBER OF REFLECTIONS : 8077 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.239 REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 388 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.82 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.03 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 407 REMARK 3 BIN R VALUE (WORKING SET) : 0.3082 REMARK 3 BIN FREE R VALUE : 0.3069 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.46 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2095 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 7 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 97.68 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.74760 REMARK 3 B22 (A**2) : -0.74760 REMARK 3 B33 (A**2) : 1.49520 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.420 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.411 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.908 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2181 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2949 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 768 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 353 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2181 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 270 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1669 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 0.91 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.36 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.71 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 14.8800 32.0860 6.5509 REMARK 3 T TENSOR REMARK 3 T11: 0.0041 T22: -0.1915 REMARK 3 T33: -0.0849 T12: 0.0539 REMARK 3 T13: 0.0618 T23: 0.0107 REMARK 3 L TENSOR REMARK 3 L11: 3.0096 L22: 5.1254 REMARK 3 L33: 3.7953 L12: 1.1281 REMARK 3 L13: 0.0088 L23: 0.6817 REMARK 3 S TENSOR REMARK 3 S11: 0.0508 S12: 0.3623 S13: 0.2321 REMARK 3 S21: -0.0740 S22: -0.1317 S23: 0.1282 REMARK 3 S31: -0.1444 S32: -0.1728 S33: 0.0808 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8CIJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1292128596. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JAN-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08B1-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97957 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8077 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.821 REMARK 200 RESOLUTION RANGE LOW (A) : 65.844 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 82.1 REMARK 200 DATA REDUNDANCY : 15.60 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.03 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 % PEG 4000, 120 MM NACL, 01. M REMARK 280 HEPES, PH = 7.75, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.98650 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 37.98800 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 37.98800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 32.99325 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 37.98800 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 37.98800 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 98.97975 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 37.98800 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 37.98800 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 32.99325 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 37.98800 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 37.98800 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 98.97975 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 65.98650 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 VAL A 3 REMARK 465 VAL A 4 REMARK 465 ASP A 5 REMARK 465 PRO A 6 REMARK 465 ASP A 7 REMARK 465 ILE A 8 REMARK 465 PHE A 9 REMARK 465 ASN A 10 REMARK 465 ARG A 11 REMARK 465 ASP A 12 REMARK 465 PRO A 13 REMARK 465 MET A 50 REMARK 465 GLU A 51 REMARK 465 PRO A 52 REMARK 465 ASP A 53 REMARK 465 CYS A 69 REMARK 465 GLY A 157 REMARK 465 ILE A 158 REMARK 465 SER A 159 REMARK 465 ALA A 160 REMARK 465 GLN A 161 REMARK 465 ILE A 162 REMARK 465 GLY A 163 REMARK 465 ALA A 164 REMARK 465 GLU A 165 REMARK 465 LEU A 166 REMARK 465 ALA A 167 REMARK 465 ARG A 168 REMARK 465 GLY A 295 REMARK 465 LYS A 296 REMARK 465 GLY A 297 REMARK 465 PRO A 298 REMARK 465 SER A 299 REMARK 465 ILE A 300 REMARK 465 GLY A 301 REMARK 465 ASP A 302 REMARK 465 ILE A 303 REMARK 465 GLU A 304 REMARK 465 ASP A 305 REMARK 465 GLU A 306 REMARK 465 GLU A 307 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 14 CG CD NE CZ NH1 NH2 REMARK 480 ASP A 15 CG OD1 OD2 REMARK 480 TYR A 17 CG CD1 CD2 CE1 CE2 CZ OH REMARK 480 ARG A 22 CG CD NE CZ NH1 NH2 REMARK 480 ARG A 35 CD NE CZ NH1 NH2 REMARK 480 VAL A 38 CG1 CG2 REMARK 480 VAL A 56 CG1 CG2 REMARK 480 SER A 57 OG REMARK 480 LEU A 59 CG CD1 CD2 REMARK 480 GLN A 60 CG CD OE1 NE2 REMARK 480 LYS A 61 CG CD CE NZ REMARK 480 GLU A 62 CG CD OE1 OE2 REMARK 480 ILE A 63 CG1 CG2 CD1 REMARK 480 LEU A 64 CG CD1 CD2 REMARK 480 ILE A 65 CG1 CG2 CD1 REMARK 480 LEU A 66 CG CD1 CD2 REMARK 480 LYS A 67 CD CE NZ REMARK 480 THR A 68 OG1 CG2 REMARK 480 ARG A 70 CD NE CZ NH1 NH2 REMARK 480 TYR A 77 CG CD1 CD2 CE1 CE2 CZ OH REMARK 480 LEU A 82 CG CD1 CD2 REMARK 480 LEU A 84 CG CD1 CD2 REMARK 480 GLN A 85 CG CD OE1 NE2 REMARK 480 LYS A 132 CG CD CE NZ REMARK 480 LEU A 221 CG CD1 CD2 REMARK 480 LEU A 224 CG CD1 CD2 REMARK 480 LYS A 238 CG CD CE NZ REMARK 480 LYS A 240 NZ REMARK 480 LYS A 261 CE NZ REMARK 480 LYS A 267 CE NZ REMARK 480 LYS A 290 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 138 109.30 -57.17 REMARK 500 LEU A 188 -51.60 -151.31 REMARK 500 LEU A 255 47.96 -97.19 REMARK 500 REMARK 500 REMARK: NULL DBREF 8CIJ A 1 307 UNP Q92918 M4K1_HUMAN 1 307 SEQADV 8CIJ GLU A 165 UNP Q92918 THR 165 CONFLICT SEQADV 8CIJ GLU A 171 UNP Q92918 SER 171 CONFLICT SEQRES 1 A 307 MET ASP VAL VAL ASP PRO ASP ILE PHE ASN ARG ASP PRO SEQRES 2 A 307 ARG ASP HIS TYR ASP LEU LEU GLN ARG LEU GLY GLY GLY SEQRES 3 A 307 THR TYR GLY GLU VAL PHE LYS ALA ARG ASP LYS VAL SER SEQRES 4 A 307 GLY ASP LEU VAL ALA LEU LYS MET VAL LYS MET GLU PRO SEQRES 5 A 307 ASP ASP ASP VAL SER THR LEU GLN LYS GLU ILE LEU ILE SEQRES 6 A 307 LEU LYS THR CYS ARG HIS ALA ASN ILE VAL ALA TYR HIS SEQRES 7 A 307 GLY SER TYR LEU TRP LEU GLN LYS LEU TRP ILE CYS MET SEQRES 8 A 307 GLU PHE CYS GLY ALA GLY SER LEU GLN ASP ILE TYR GLN SEQRES 9 A 307 VAL THR GLY SER LEU SER GLU LEU GLN ILE SER TYR VAL SEQRES 10 A 307 CYS ARG GLU VAL LEU GLN GLY LEU ALA TYR LEU HIS SER SEQRES 11 A 307 GLN LYS LYS ILE HIS ARG ASP ILE LYS GLY ALA ASN ILE SEQRES 12 A 307 LEU ILE ASN ASP ALA GLY GLU VAL ARG LEU ALA ASP PHE SEQRES 13 A 307 GLY ILE SER ALA GLN ILE GLY ALA GLU LEU ALA ARG ARG SEQRES 14 A 307 LEU GLU PHE ILE GLY THR PRO TYR TRP MET ALA PRO GLU SEQRES 15 A 307 VAL ALA ALA VAL ALA LEU LYS GLY GLY TYR ASN GLU LEU SEQRES 16 A 307 CYS ASP ILE TRP SER LEU GLY ILE THR ALA ILE GLU LEU SEQRES 17 A 307 ALA GLU LEU GLN PRO PRO LEU PHE ASP VAL HIS PRO LEU SEQRES 18 A 307 ARG VAL LEU PHE LEU MET THR LYS SER GLY TYR GLN PRO SEQRES 19 A 307 PRO ARG LEU LYS GLU LYS GLY LYS TRP SER ALA ALA PHE SEQRES 20 A 307 HIS ASN PHE ILE LYS VAL THR LEU THR LYS SER PRO LYS SEQRES 21 A 307 LYS ARG PRO SER ALA THR LYS MET LEU SER HIS GLN LEU SEQRES 22 A 307 VAL SER GLN PRO GLY LEU ASN ARG GLY LEU ILE LEU ASP SEQRES 23 A 307 LEU LEU ASP LYS LEU LYS ASN PRO GLY LYS GLY PRO SER SEQRES 24 A 307 ILE GLY ASP ILE GLU ASP GLU GLU HET USF A 401 38 HETNAM USF 2-[[8-AZANYL-7-FLUORANYL-6-(8-METHYL-2,3-DIHYDRO-1~{H}- HETNAM 2 USF PYRIDO[2,3-B][1,4]OXAZIN-7-YL)ISOQUINOLIN-3-YL]AMINO]- HETNAM 3 USF 6-PROPAN-2-YL-5,8-DIHYDRO-4~{H}-PYRAZOLO[1,5-D][1, HETNAM 4 USF 4]DIAZEPIN-7-ONE HETSYN USF 2-[8-AMINO-7-FLUORO-6-(8-METHYL-2,3-DIHYDRO-1H- HETSYN 2 USF PYRIDO[2,3-B][1,4]OXAZIN-7-YL)-ISOQUINOLIN-3-YLAMINO]- HETSYN 3 USF 6-ISOPROPYL-5,6-DIHYDRO-4H-1,6,8A-TRIAZA-AZULEN-7-ONE FORMUL 2 USF C27 H29 F N8 O2 FORMUL 3 HOH *7(H2 O) HELIX 1 AA1 ASP A 55 THR A 68 1 14 HELIX 2 AA2 SER A 98 GLY A 107 1 10 HELIX 3 AA3 SER A 110 GLN A 131 1 22 HELIX 4 AA4 LYS A 139 ILE A 143 5 5 HELIX 5 AA5 THR A 175 MET A 179 5 5 HELIX 6 AA6 ALA A 180 ALA A 185 1 6 HELIX 7 AA7 VAL A 186 LEU A 188 5 3 HELIX 8 AA8 LEU A 195 LEU A 211 1 17 HELIX 9 AA9 HIS A 219 MET A 227 1 9 HELIX 10 AB1 SER A 244 LEU A 255 1 12 HELIX 11 AB2 SER A 264 SER A 270 1 7 HELIX 12 AB3 ARG A 281 ASN A 293 1 13 SHEET 1 AA1 5 TYR A 17 LEU A 23 0 SHEET 2 AA1 5 VAL A 31 ASP A 36 -1 O ARG A 35 N ASP A 18 SHEET 3 AA1 5 LEU A 42 VAL A 48 -1 O VAL A 43 N ALA A 34 SHEET 4 AA1 5 LYS A 86 GLU A 92 -1 O ILE A 89 N LYS A 46 SHEET 5 AA1 5 TYR A 77 TRP A 83 -1 N GLY A 79 O CYS A 90 SHEET 1 AA2 2 LEU A 144 ILE A 145 0 SHEET 2 AA2 2 VAL A 151 ARG A 152 -1 O ARG A 152 N LEU A 144 CRYST1 75.976 75.976 131.973 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013162 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013162 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007577 0.00000